Comparison of the sales profile of azithromycin before and during the COVID-19 pandemic in the interior of Bahia
DOI:
https://doi.org/10.5020/18061230.2023.13933Keywords:
COVID-19, Azithromycin, Assisted selling medicines, Use of medicationsAbstract
Objective: to characterize the profile of azithromycin sales during the COVID-19 pandemic and compare this profile with the previous year in a municipality in the interior of Bahia. Methods: This is a cross-sectional study with an analytical descriptive design. The sample data were extracted from the database of the National Controlled Products Management System of the National Health Surveillance Agency, municipality of Jequié, years 2019, 2020 and 2021. Pearson’s Chi-square test was used to compare the proportions of categorical variables. The relationship between continuous variables was carried out using the simple linear regression model. A significance level of 0.05 was adopted. Results: It was found that the coated tablet was the best-selling in all years, especially in 2020, representing 89% of sales; the 18-59 age group reached the highest frequency in 2020 with 73.5%. The prescriber’s class council was, predominantly, the Regional Council of Medicine, which had a total of 92.7% of prescriptions in 2019, 91.4% in 2020 and 92.2% in 2021. There was a statistical association between pharmaceutical form and sex. A correlation was observed between the quantity of azithromycin sold and the number of confirmed cases of COVID-19 (r=0.931, p<0.001, R2=0.867). Conclusion: There was an increase in the sale of the antimicrobial azithromycin, with a correlation between the quantity sold and the number of confirmed cases of COVID-19, linked to encouraging the irrational use of medicines, which reinforces the need to include the pharmacist as an agent essential in health promotion and health education actions
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Larissa Félix dos Santos, Gisele da Silveira Lemos, Nara Jacqueline Souza dos Santos

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Upon publishing in the RBPS, the authors declare that the work is their exclusive authorship and therefore assume full responsibility for its content. Along with the submission of the manuscript, authors must provide the Statement of Responsibility and Copyright signed by all authors, as well as their individual contribution to its preparation, and it must be submitted in PDF format. The authors retain the copyright of their article and agree to license their work under an International Creative Commons Public License, thereby accepting the terms and conditions of this license.
CC BY-NC: This license permits others to remix, adapt, and build upon the published article for non-commercial purposes, provided that proper credit is attributed to the creators of the work (the authors of the article).
License link: https://creativecommons.org/licenses/by-nc/4.0
Legal code: https://creativecommons.org/licenses/by-nc/4.0/legalcode
















